Biofilms Treatment Market Size and Growth 2031

The biofilms treatment market size in 2021 stood at US$ 1.82 billion and is projected to reach US$ 3.88 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 8.0% in 2023–2031. Growing strategic developments such as product launch and product approval and development of new technologies are likely to remain key biofilms treatment market trends.

Biofilms Treatment Market Analysis

The increasing incidence of wounds and infections and the spread of biofilms on medical devices increase the demand for biofilm treatment thereby boosting the market globally. Furthermore, the increasing prevalence of biofilms is an additional factor that is expected to increase market growth during the forecast period. According to some studies, biofilms are present in 60 to 100% of chronic wound samples. This factor represents biofilms' faster and spatial distribution in chronic wounds, which would require optimal treatment of the biofilms. Technological improvements, the development of novel products, and the entry of new players in biofilm treatment are likely to expand the market at the global level. Factors such as rising infections related to biofilms and antibiotic resistance, as well as the high cost and low adoption of advanced wound care products, are also potential restraints hampering the overall growth of the global biofilm treatment market.  

Biofilms Treatment Market Overview

Rising healthcare expenditure, an aging population more prone to chronic wounds, new product launches, and favorable reimbursement scenarios drive market growth. Regulatory authorities are increasingly recognizing the impact of biofilm-related infections on public health. Strict regulations and guidelines are being developed to prevent and treat biofilm-related infections, increasing the demand for compliant biofilm treatment solutions. Companies actively pursue technological advances and innovations to improve biofilm treatment beyond traditional methods. These innovations may include the development of advanced wound dressings with improved antimicrobial properties, the integration of smart materials to detect and combat biofilms, and the exploration of targeted drug delivery systems to respond to bacteria embedded in biofilms. Additionally, research efforts are underway to utilize new technologies, such as biotechnology and nanotechnology, for developing more effective and efficient solutions for biofilm treatment.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Biofilms Treatment Market: Strategic Insights

Market Size Value in	US$ 1,590.31 Million in 2019
Market Size Value by	US$ 2,825.80 Million by 2027
Growth rate	CAGR of 7.5% from 2020-2027
Forecast Period	2020-2027
Base Year	2020

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Biofilms Treatment Market Drivers and Opportunities

Rising Incidence of Chronic, Surgical, and Traumatic Wounds to Favor Market

According to the International Diabetes Federation study—Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045—the prevalence of diabetes in 2019 was around 9.3% that is about 463 million people. It is expected to reach 10.2% that is around 578 million, by 2030. Biofilms also significantly impact the lungs and digestive systems of patients with cystic fibrosis (CF). More than 70,000 people live with CF worldwide, around 30,000 of whom live in the US. Biofilms in the CF lung is highly resistant to antibiotic treatment. They contribute significantly to the overall economic impact of CF, amounting to an estimated US$ 7,509 million per year worldwide. Moreover, advanced medical technologies have led to increase in number of surgeries. According to the National Nosocomial Infections Surveillance System, annually ~27 million surgical procedures are executed in the US, of which, around 5% result in surgical site infections.

Increasing Research in Emerging Economies– An Opportunity for Biofilms Treatment Market Growth

The increasing awareness regarding the importance of microbial biofilms in various sectors continues to reveal new opportunities for developing innovative technologies in translational research that can address their harmful effects and exploit their benefits. Ongoing research focuses on developing novel compounds that can be used with antibiotics to fight infections. Advanced strategies or innovative approaches are required to prevent and eradicate clinically important infections, especially at the nanoscale. Understanding how biofilms promote infection and antibiotic resistance is critical to developing effective approaches to treat infections caused by nosocomial pathogens. The synthesis of advanced multifunctional nanomaterials that simultaneously enable diagnosis and therapy has become an area of great interest in contemporary research. Advances in transcriptomics, metabolomics, and transposon-based next-generation sequencing may reveal new genetic targets for biofilm research.

In the meantime, novel antibiofilm agents targeting biofilm-specific bacterial components must be discovered. Nanoparticle-based antibiofilm agents represent an emerging area of research that has shown promising results in combating bacterial biofilms, particularly when multiple agents are used. In April 2021, MSU expanded its biofilm research capabilities with a US$ 513,000 grant from the Murdock Trust. Therefore, the ongoing studies and research are expected to positively impact the biofilms treatment, thereby providing lucrative opportunities for market growth.

Biofilms Treatment Market Report Segmentation Analysis

Key segments that contributed to the derivation of the biofilms treatment market analysis are product, wound type, and end user.

• Based on product, the biofilms treatment market is divided into debridement equipment, gauzes and dressings, grafts and matrices, and others. The gauzes and dressings segment held the largest share of the market in 2023 and the same segment is anticipated to register the highest CAGR during the forecast period.
• By wound type, the market is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other wounds. The traumatic and surgical wounds segment held the largest share of the market in 2023, and the same segment is anticipated to register the highest CAGR during 2023–2031.
• In terms of end user, the market is segmented into hospitals, home care settings, and other end users. The hospitals segment held the largest share of the market in 2023. Also, the same segment is estimated to register the highest CAGR during the forecast period.

Biofilms Treatment Market Share Analysis by Geography

The geographic scope of the biofilms treatment market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the biofilms treatment market. The growth of the market in North America is attributed to the rise in the prevalence of diabetes as well as presence of associations providing wound care solutions. In North America, the biotechnology sector in plays an important role in developing biofilms treatment. Diabetic Mellitus (DM) is recognized to have an epidemic prevalence in the US as compared to the incidences of the condition across the globe. With an increase in the number of diabetic patients, a rise in complications associated are also anticipated to increase. Various organizations and journals have published preferred practices to heal and close DFU. However, in spite of the suggested guidelines, only 50% of diabetic foot ulcers are recovered within a year in the US. Wounds Canada, formerly known as the Canadian Association of Wound Care, is a non-profit organization which works towards the advancement of wound prevention and management in Canada. The organization focuses primarily on four key areas, education, research, advocacy & awareness, and partnerships. Mexican Association for Wound Care and Healing, a non-profit civil organization, composed of a multidisciplinary group of specialists dedicated to the study of wounds and stomata in Mexico. The association promotes comprehensive care and access to wound and stoma treatments, with the help of health personnel, to improve the patient's quality of life. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.  

Biofilms Treatment Market Report Scope

Biofilms Treatment Market News and Recent Developments

The biofilms treatment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for biofilms treatment:

• The Cystic Fibrosis Foundation invested up to US$5 million in Clarametyx Biosciences to develop CMTX-101, a drug that could help address difficult-to-treat bacteria such as chronic Pseudomonas aeruginosa, a major cause of lung infections in people with cystic fibrosis. (Cystic Fibrosis Foundation, News, 2024)
• Trellis Bioscience Inc., a pioneering biotechnology company focused on the discovery and development of native human monoclonal antibodies, announced that its lead antibody candidate, TRL1068, had been granted Fast Track and QIDP designations by the US Food and Drug Administration (FDA). (Source: Trellis Bioscience, Inc., News, 2024)
• Asep Medical Holdings Inc. announced the use of artificial intelligence (AI) that enabled the development of new and improved treatments for common biofilm infections and rapid sepsis diagnostics. (Source: ASEP Medical Holdings Inc., News, 2024)
• Medline and OMNIA Partners announced new purchasing partnership. The agreement offered medical-surgical product portfolio cost savings to public sector agencies. Eligible public agencies included state, county and local government, primary and higher education systems and public safety services will be able to tap into Medline’s full portfolio of more than 300,000 medical supplies. (Medline Industries, LP, Press Release, 2022)

Biofilms Treatment Market Report Coverage and Deliverables

The “Biofilms TreatmentMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles